Related references
Note: Only part of the references are listed.Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a
Jianwen Wei et al.
DIABETES (2014)
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
J. Bolinder et al.
DIABETES OBESITY & METABOLISM (2014)
Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women
A. L. Schafer et al.
DIABETIC MEDICINE (2014)
Fracture risk in diabetic elderly men: the MrOS study
Nicola Napoli et al.
DIABETOLOGIA (2014)
The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
Andrew Grey et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
Joshua N. Farr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Effects of Estrogen on Bone mRNA Levels of Sclerostin and Other Genes Relevant to Bone Metabolism in Postmenopausal Women
Koji Fujita et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults
R. Armamento-Villareal et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Unlocking the biology of RAGE in diabetic microvascular complications
Michaele B. Manigrasso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
One size does not fit all glycemic targets for type 2 diabetes
Paolo Pozzilli et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes
Ernesto Maddaloni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes
Mohammed-Salleh M. Ardawi et al.
BONE (2013)
Anti-Diabetes Drug Class of SGLT1 Inhibitors Increases Bone Mass in Young and Adult Female Sprague-Dawley Rats by Decreasing Bone Turnover
Rana Samadfam et al.
Canadian Journal of Diabetes (2013)
The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity
H. Sadie-Van Gijsen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
High-Dose Vitamin D Supplementation in People With Prediabetes and Hypovitaminosis D
Mayer B. Davidson et al.
DIABETES CARE (2013)
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus
R. Strollo et al.
DIABETOLOGIA (2013)
The Effect of Rosiglitazone on Bone Mass and Fragility Is Reversible and Can Be Attenuated With Alendronate
Sanjay Kumar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
Christine Hamann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
Xue Ma et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women With Fragility Fractures
Janina M. Patsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study
Henry G. Bone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Risk Factors for Subtrochanteric and Diaphyseal Fractures: The Study of Osteoporotic Fractures
Nicola Napoli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk
William D. Leslie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis
Franck Oury et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
Guillaume Mabilleau et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Amylin exerts osteogenic actions with different efficacy depending on the diabetic status
I. Gutierrez-Rojas et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
Ju-Young Kim et al.
LIFE SCIENCES (2013)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
Nicola Napoli et al.
PLOS ONE (2013)
Bone Health As a Function of Adipokines and Vitamin D Pattern in Elderly Patients
Claudio Pedone et al.
REJUVENATION RESEARCH (2013)
Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation
Gregorio Chazenbalk et al.
STEROIDS (2013)
SGLT inhibitors in management of diabetes
Abd A. Tahrani et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Obesity and Bone
Juliet Compston
CURRENT OSTEOPOROSIS REPORTS (2013)
Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
Jakob Starup-Linde
Frontiers in Endocrinology (2013)
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
M. Neale Weitzmann
SCIENTIFICA (2013)
Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir
Francisco Santiago et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus
Laura A. G. Armas et al.
BONE (2012)
Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials
M. G. Valorani et al.
CELL PROLIFERATION (2012)
Marrow Fat and the Bone Microenvironment: Developmental, Functional, and Pathological Implications
Clifford J. Rosen et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Effects of anti-tumor necrosis factor a agents on bone
Vivian K. Kawai et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial
Ann V. Schwartz et al.
DIABETES CARE (2012)
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2012)
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
O. Ljunggren et al.
DIABETES OBESITY & METABOLISM (2012)
Receptor activator of nuclear factor-?B ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice
Nozomu Sakai et al.
HEPATOLOGY (2012)
High Serum Sclerostin Predicts the Occurrence of Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training
Reina Armamento-Villareal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Type 2 Diabetes and Bone
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival
Katherine J. Motyl et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
Aarthi Arasu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Osteogenic Precursor Cells in Type 2 Diabetes Mellitus
J. S. Manavalan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
Kazuhiro Maeda et al.
NATURE MEDICINE (2012)
Inflammatory bone loss: pathogenesis and therapeutic intervention
Kurt Redlich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women
Nicola Napoli et al.
MATURITAS (2012)
How metabolic acidosis and oxidative stress alone and interacting may increase the risk of fracture in diabetic subjects
L. A. Frassetto et al.
MEDICAL HYPOTHESES (2012)
Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes
K. M. Thrailkill et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects
V. Bousson et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Bone structure and turnover in type 2 diabetes mellitus
A. Shu et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls
Janet M. Pritchard et al.
ARTHRITIS CARE & RESEARCH (2012)
The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective
Wilfred Ip et al.
CELL AND BIOSCIENCE (2012)
Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells
S. Benvenuti et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2012)
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
Michael A. Nauck
AMERICAN JOURNAL OF MEDICINE (2011)
Effect of ghrelin on bone mass density: The In Chianti study
Nicola Napoli et al.
BONE (2011)
Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2
Won Gu Jang et al.
BONE (2011)
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
Ulrike I. Moedder et al.
BONE (2011)
Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes?
Peter Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Risk of Newly Diagnosed Type 2 Diabetes Is Reduced in Users of Alendronate
Peter Vestergaard
CALCIFIED TISSUE INTERNATIONAL (2011)
The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease
P. Grigoropoulou et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial
H. J. Choi et al.
DIABETES CARE (2011)
Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures A meta-analysis of randomized clinical trials
Matteo Monami et al.
DIABETES CARE (2011)
Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
Christina Wang et al.
DIABETES CARE (2011)
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients
J. L. C. Borges et al.
DIABETES OBESITY & METABOLISM (2011)
Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients
Malgorzata Walus-Miark et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Ann V. Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men
Ulrike Il Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Bone Microarchitecture Assessed by TBS Predicts Osteoporotic Fractures Independent of Bone Density: The Manitoba Study
Didier Hans et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Skeletal Phenotype of the Leptin Receptor-Deficient db/db Mouse
Garry A. Williams et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Why the IOM Recommendations for Vitamin D Are Deficient
Robert P. Heaney et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Resveratrol Promotes Osteogenesis of Human Mesenchymal Stem Cells by Upregulating RUNX2 Gene Expression via the SIRT1/FOXO3A Axis
Pei-Chi Tseng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Exercise Training in Obese Older Adults Prevents Increase in Bone Turnover and Attenuates Decrease in Hip Bone Mineral Density Induced by Weight Loss Despite Decline in Bone-Active Hormones
Krupa Shah et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Metformin Stimulates Osteoprotegerin and Reduces RANKL Expression in Osteoblasts and Ovariectomized Rats
Qi-Guang Mai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
The Bone Marrow Microenvironment Contributes to Type I Diabetes Induced Osteoblast Death
Lindsay M. Coe et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Correlations Between Trabecular Bone Score, Measured Using Anteroposterior Dual-Energy X-Ray Absorptiometry Acquisition, and 3-Dimensional Parameters of Bone Microarchitecture: An Experimental Study on Human Cadaver Vertebrae
Didier Hans et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Influence of Adipokines and Ghrelin on Bone Mineral Density and Fracture Risk: A Systematic Review and Meta-Analysis
Emmanuel Biver et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Determination of Serum and Plasma Sclerostin Concentrations by Enzyme-Linked Immunoassays
Melissa McNulty et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Weight Loss, Exercise, or Both and Physical Function in Obese Older Adults
Dennis T. Villareal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vertebral Bone Marrow Fat Is Positively Associated With Visceral Fat and Inversely Associated With IGF-1 in Obese Women
Miriam A. Bredella et al.
OBESITY (2011)
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus
I. Kanazawa et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Diabetes, falls and fractures
Deborah Mayne et al.
AGE AND AGEING (2010)
Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow
C. Sanz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Adiponectin and bone mass density The InCHIANTI study
Nicola Napoli et al.
BONE (2010)
Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism
Mathieu Ferron et al.
CELL (2010)
Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential
M. G. Valorani et al.
CELL AND TISSUE RESEARCH (2010)
TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Dennis T. Villareal et al.
DIABETES (2010)
Dietary Phylloquinone and Menaquinones Intakes and Risk of Type 2 Diabetes
Joline W. J. Beulens et al.
DIABETES CARE (2010)
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
Stavros C. Manolagas
ENDOCRINE REVIEWS (2010)
Alterations of the Wnt/β-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice
S. Portal-Nunez et al.
FEBS LETTERS (2010)
Bone Mass and Strength in Older Men With Type 2 Diabetes: The Osteoporotic Fractures in Men Study
Moira A. Petit et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Presence of a Functional Receptor for GLP-1 in Osteoblastic Cells, Independent of the cAMP-Linked GLP-1 Receptor
Bernardo Nuche-Berenguer et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus
Andrew J. Burghardt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Bernard Zinman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
PPARγ: a circadian transcription factor in adipogenesis and osteogenesis
Masanobu Kawai et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
Bernardo Nuche-Berenguer et al.
REGULATORY PEPTIDES (2010)
Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice
Alexander Elbaz et al.
BIOGERONTOLOGY (2009)
Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes
Peter Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Yoon K. Loke et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
WNT/β-catenin increases the production of incretins by entero-endocrine cells
J. M. Garcia-Martinez et al.
DIABETOLOGIA (2009)
In Vitro and in Vivo Effects of Adiponectin on Bone
Garry A. Williams et al.
ENDOCRINOLOGY (2009)
Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals
Mi Zhou et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Sex Differences in the Association Between Adiponectin and BMD, Bone Loss, and Fractures: The Rancho Bernardo Study
Maria Rosario G. Araneta et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men
Jenny M. Kindblom et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications
Masahiro Yamamoto et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
PPARγ2 Nuclear Receptor Controls Multiple Regulatory Pathways of Osteoblast Differentiation From Marrow Mesenchymal Stem Cells
Keith R. Shockley et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Leptin Treatment Prevents Type I Diabetic Marrow Adiposity But Not Bone Loss in Mice
Katherine J. Motyl et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Evaluation of the Potential Use of Trabecular Bone Score to Complement Bone Mineral Density in the Diagnosis of Osteoporosis: A Preliminary Spine BMD-Matched, Case-Control Study
Laurent Pothuaud et al.
JOURNAL OF CLINICAL DENSITOMETRY (2009)
Association between Serum Osteocalcin and Markers of Metabolic Phenotype
Anastassios G. Pittas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
Ann V. Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus
Ippei Kanazawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
H. A. Bischoff-Ferrari et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study
Manuel Sosa et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Pentosidine effects on human osteoblasts in vitro
Roberta Sanguineti et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men
S. Gonnelli et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Combination of Obesity with Hyperglycemia is a Risk Factor for the Presence of Vertebral Fractures in Type 2 Diabetic Men
Ippei Kanazawa et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo
Heather E. Fleming et al.
CELL STEM CELL (2008)
Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men
Xiao-Ding Peng et al.
CLINICA CHIMICA ACTA (2008)
Effect of Vitamin K Supplementation on Insulin Resistance in Older Men and Women
Makiko Yoshida et al.
DIABETES CARE (2008)
Rosiglitazone-associated fractures in type 2 diabetes - An analysis from a diabetes outcome progression trial (ADOPT)
Steven E. Kahn et al.
DIABETES CARE (2008)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
The murine glucagon-like peptide-1 receptor is essential for control of bone resorption
Chizumi Yamada et al.
ENDOCRINOLOGY (2008)
Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes
Ann V. Schwartz et al.
EXPERT OPINION ON DRUG SAFETY (2008)
R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression
Wenyan Lu et al.
FEBS LETTERS (2008)
Fracture risk in type 2 diabetes: Update of a population-based study
L. Joseph I. I. I. I. Melton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
The pro-osteogenic action of β-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity
Valerie S. Salazar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Serum adiponectin in elderly men does not correlate with fracture risk
Karl Michaelsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults
Natascia Di Iorgi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
Mathieu Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo
Yu Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
High glucose induces adipogenic differentiation of muscle-derived stem cells
Paola Aguiari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Diabetes-related complications, glycemic control, and falls in older adults
Ann V. Schwartz et al.
DIABETES CARE (2008)
Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients A case-control study
Matteo Monami et al.
DIABETES CARE (2008)
Understanding the pathology and mechanisms of type I diabetic bone loss
Laura R. McCabe
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
A histone lysine methyltransferase activated by non- canonical Wnt signalling suppresses PPAR-γ transactivation
Ichiro Takada et al.
NATURE CELL BIOLOGY (2007)
Gone with the Wnts:: β-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism
Stavros C. Manolagas et al.
MOLECULAR ENDOCRINOLOGY (2007)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
Exposure to hydrogen peroxide diminishes NF-κB activation, IκB-α degradation, and proteasome activity in neutrophils
Jaroslaw W. Zmijewski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Relationship of obesity with osteoporosis
Lan-Juan Zhao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women
W. Shen et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Serum adiponectin and bone mineral density in women
J. B. Richards et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The risk of hip fractures in older individuals with diabetes - A population-based study
Lorraine L. Lipscombe et al.
DIABETES CARE (2007)
Estrogen metabolism modulates bone density in men
N. Napoli et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Osteoporosis in patients with diabetes mellitus
Lorenz C. Hofbauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction
Paola Secchiero et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Antiobesity effects of the β-cell hormone amylin in diet-induced obese rats:: Effects on food intake, body weight, composition, energy expenditure, and gene expression
Jonathan D. Roth et al.
ENDOCRINOLOGY (2006)
Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae
S. Viguet-Carrin et al.
BONE (2006)
Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism
Liv Thommesein et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways
Sergiu Botolin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans
Reiko Nakashima et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways
Yusuke Shinoda et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Risk of fracture in women with type 2 diabetes: The Women's Health Initiative Observational Study
Denise E. Bonds et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Prospective study of diabetes and risk of hip fracture - The Nurses' Health Study
Mohsen Janghorbani et al.
DIABETES CARE (2006)
Wnt signaling and osteoblastogenesis
Peter V. N. Bodine et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2006)
Playing with bone and fat
JM Gimble et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Ghrelin and bone: Is there an association in older adults?: The Rancho Bernardo study
LA Weiss et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity
Y Liu et al.
ACTA PHARMACOLOGICA SINICA (2006)
Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells
P Malladi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study
LA Ahmed et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions
JH Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NFκB pathways
XH Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
SFA Grant et al.
NATURE GENETICS (2006)
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts
H Kaneki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Glycation endproducts in osteoporosis - Is there a pathophysiologic importance?
Gert E. Hein
CLINICA CHIMICA ACTA (2006)
Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors
R Singh et al.
ENDOCRINOLOGY (2006)
Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a
PJD Delhanty et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Risk factors for falls in older disabled women with diabetes: The women's health and aging study
S Volpato et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Elevated hip fracture risk in type 1 diabetic patients
JM Miao et al.
DIABETES CARE (2005)
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption
H Michael et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Interleukin-6 and diabetes - The good, the bad, or the indifferent?
OP Kristiansen et al.
DIABETES (2005)
Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus
P Gerdhem et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
II de Liefde et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
KM Thrailkill et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes
P Pozzilli et al.
HORMONE AND METABOLIC RESEARCH (2005)
Interleukin-6: An osteotropic factor influencing bone formation?
N Franchimont et al.
BONE (2005)
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone
S Kume et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells
SW Kim et al.
BONE (2005)
Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice
S Botolin et al.
ENDOCRINOLOGY (2005)
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
KES Poole et al.
FASEB JOURNAL (2005)
The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men
KW Oh et al.
CLINICAL ENDOCRINOLOGY (2005)
11β-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
N Draper et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults - The health, aging, and body composition study
ES Strotmeyer et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk
P Vestergaard et al.
DIABETOLOGIA (2005)
Predictive value of BMD for hip and other fractures
O Johnell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent mechanisms
JA Kennell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast
K Oshima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Circulating osteoblast-lineage cells in humans
GZ Eghbali-Fatourechi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Fracture prevention with vitamin D supplementation - A meta-analysis of randomized controlled trials
HA Bischoff-Ferrari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Ghrelin directly regulates bone formation
N Fukushima et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
TF Day et al.
DEVELOPMENTAL CELL (2005)
Voluntary weight reduction in older men increases hip bone loss: The Osteoporotic Fractures in Men study
KE Ensrud et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake
CS Riedt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Ghrelin regulates proliferation and differentiation of osteoblastic cells
G Maccarinelli et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Sequential roles of Hedgehog and Wnt signaling in osteoblast development
HL Hu et al.
DEVELOPMENT (2005)
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans
JN Fain et al.
ENDOCRINOLOGY (2004)
Plasma adiponectin levels and risk of myocardial infarction in men
T Pischon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Impairment of bone healing by insulin receptor substrate-1 deficiency
T Shimoaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women
MD Kontogianni et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Leptin deficiency produces contrasting phenotypes in bones of the limb and spine
MW Hamrick et al.
BONE (2004)
Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance:: Studies in young adult monozygotic twins
K Kannisto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serum leptin level and the risk of nontraumatic fracture
G Schett et al.
AMERICAN JOURNAL OF MEDICINE (2004)
11β-hydroxysteroid dehydrogenases:: changing glucocorticoid action
JR Seckl
CURRENT OPINION IN PHARMACOLOGY (2004)
Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women - The fracture intervention trial
THM Keegan et al.
DIABETES CARE (2004)
Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines:: Relationships in obesity
J Vendrell et al.
OBESITY RESEARCH (2004)
Regulation of 11 beta-HSD genes in human adipose tissue: Influence of central obesity and weight loss
S Engeli et al.
OBESITY RESEARCH (2004)
Physical activity, body size, and estrogen metabolism in women
CE Matthews et al.
CANCER CAUSES & CONTROL (2004)
Adipose tissue as an endocrine organ
EE Kershaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
11β-hydroxysteroid dehydrogenase type 1:: A tissue-specific regulator of glucocorticoid response
JW Tomlinson et al.
ENDOCRINE REVIEWS (2004)
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
AD McCarthy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis
M Moldes et al.
BIOCHEMICAL JOURNAL (2003)
Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women
KE Ensrud et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Adiponectin as a novel determinant of bone mineral density and visceral fat
L Lenchik et al.
BONE (2003)
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
H Glantschnig et al.
CELL DEATH AND DIFFERENTIATION (2003)
High bone mass in mice expressing a mutant LRP5 gene
P Babij et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Insulin resistance and chronic cardiovascular inflammatory syndrome
JM Fernández-Real et al.
ENDOCRINE REVIEWS (2003)
Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans
M Yannakoulia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Superoxide anions induce the maturation of human dendritic cells
S Kantengwa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Resistin release by human adipose tissue explants in primary culture
JN Fain et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Resistin is expressed in human macrophages and directly regulated by PPARγ activators
L Patel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
T Fujino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Deletion of ghrelin impairs neither growth nor appetite
YX Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The interieukin 6-174G/C Polymorphism is associated with indices of obesity in men
MT Berthier et al.
JOURNAL OF HUMAN GENETICS (2003)
Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer
C Wallace et al.
DIABETES CARE (2002)
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
J Cornish et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts
T Akune et al.
JOURNAL OF CELL BIOLOGY (2002)
p38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose
M Zayzafoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Amylin, food intake, and obesity
TK Reda et al.
OBESITY RESEARCH (2002)
Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis
S Verma et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Regulation of Wnt signaling during adipogenesis
CN Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Microarray analyses during adipogenesis:: Understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor α in adipocyte metabolism
SE Ross et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) α or β
R Okazaki et al.
ENDOCRINOLOGY (2002)
Adipogenesis and aging: does aging make fat go MAD?
JL Kirkland et al.
EXPERIMENTAL GERONTOLOGY (2002)
Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure
MS Cooper et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
M Kato et al.
JOURNAL OF CELL BIOLOGY (2002)
Leptin inhibits osteoclast generation
WR Holloway et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α
L Gilbert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Amylin and adrenomedullin: Novel regulators of bone growth
J Cornish et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling
JO Gordeladze et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
RD Little et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women
M Yamauchi et al.
CLINICAL ENDOCRINOLOGY (2001)
Estrogen production and action
LR Nelson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Leptin reduces ovariectomy-induced bone loss in rats
B Burguera et al.
ENDOCRINOLOGY (2001)
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women
KK Nicodemus et al.
DIABETES CARE (2001)
Diabetes and risk of fracture - The Blue Mountains Eye Study
RQ Ivers et al.
DIABETES CARE (2001)
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
C Weyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Coincident diabetes mellitus and primary hyperparathyroidism
WH Taylor et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
The hormone resistin links obesity to diabetes
CM Steppan et al.
NATURE (2001)
Older women with diabetes have an increased risk of fracture: A prospective study
AV Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Glucose-induced inhibition of in vitro bone mineralization
E Balint et al.
BONE (2001)
Bone mineral changes in obese women during a moderate weight loss with and without calcium supplementation
LB Jensen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis
J Justesen et al.
BIOGERONTOLOGY (2001)
The oxidative metabolism of estradiol conditions postmenopausal bone density and bone loss
R Leelawattana et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Expression and functional consequences of 11-β-hydroxysteroid dehydrogenase activity in human bone
MS Cooper et al.
BONE (2000)
Effect of voluntary weight loss on bone mineral density in older overweight women
D Chao et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2000)
Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: Synergy with dexamethasone
CD Richards et al.
CYTOKINE (2000)
Insulin receptor substrate-1 in osteoblast is indispensible for maintaining bone turnover
N Ogata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
P Ducy et al.
CELL (2000)
Radicals and oxidative stress in diabetes
IC West
DIABETIC MEDICINE (2000)
Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: A prospective study
MMC Pastor et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
